RxNorm Semantic Concepts Index - 247
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "247".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 2470003 | zinc pyrithione 2 MG/ML [Head & Shoulders] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2470004 | Head & Shoulders 0.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2470004 | Head & Shoulders 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2470004 | Head & Shoulders 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2470004 | Head & Shoulders 0.2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2470030 | Agastache foeniculum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2470031 | Baptisia australis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2470130 | Solanum nigrum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 247018 | dimenhyDRINATE 2.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247018 | dimenhyDRINATE 2.5 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2470230 | ethanol 0.748 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2470231 | ethanol 74.8 % / benzalkonium chloride 0.1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2470231 | ethanol 74.8 % / benzalkonium chloride 0.1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2470232 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2470233 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2470234 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 100 MCG/0.5 ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2470234 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 100 MCG/0.5 ML Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2470234 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 100 MCG/0.5 ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247035 | penicillin G 100000 UNT/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247036 | penicillin V 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247037 | bacampicillin 800 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247038 | cloxacillin 132 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247039 | cloxacillin 294 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247040 | pyrvinium 10 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247042 | budesonide 50 MCG/ACTUAT Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247042 | budesonide 50 MCG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247042 | budesonide 50 MCG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247042 | budesonide 50 MCG/ACTUAT Nasal Spray | Designated preferred name (PT) | NO | |
| RxCUI: 247042 | budesonide 50 MCG/ACTUAT Nasal Spray | Full form of descriptor (FN) | NO | |
| RxCUI: 247044 | albuterol 0.05 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247046 | theophylline 325 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247047 | budesonide 200 MCG/ACTUAT Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247047 | budesonide 200 MCG/ACTUAT Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247047 | budesonide 200 MCG/ACTUAT Inhalation Powder | Designated preferred name (PT) | NO | |
| RxCUI: 247047 | budesonide 200 MCG/ACTUAT Inhalation Powder | Designated preferred name (PT) | NO | |
| RxCUI: 247047 | budesonide 200 MCG/ACTUAT Inhalation Powder | Full form of descriptor (FN) | NO | |
| RxCUI: 247047 | budesonide 200 MCG/ACTUAT Inhalation Powder | Full form of descriptor (FN) | NO | |
| RxCUI: 247049 | fiber 469 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247050 | lactulose 0.4 MG/MG Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247051 | diphenoxylate 0.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247052 | aluminum hydroxide 80 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247053 | aluminum hydroxide 20 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2470531 | behenyl betaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2470532 | Cyclavance | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2470533 | cyclosporine, modified 100 MG/ML [Cyclavance] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2470533 | cyclosporine, modified 100 MG/ML [Cyclavance] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2470534 | cyclosporine Oral Solution [Cyclavance] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2470534 | cyclosporine Oral Solution [Cyclavance] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2470535 | Cyclavance Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2470536 | Cyclavance Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2470537 | Cyclavance 100 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2470537 | Cyclavance 100 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2470537 | Cyclavance 100 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2470537 | Cyclavance 100 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2470538 | dimethicone/peg-10/15 crosspolymer in dimethicone 6 (130000 cps) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 247054 | mesalamine 500 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247054 | mesalamine 500 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247055 | metroNIDAZOLE 10 % Vaginal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247055 | metroNIDAZOLE 10 % Vaginal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247055 | metroNIDAZOLE 10 % Vaginal Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 247055 | metroNIDAZOLE 10 % Vaginal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247055 | metroNIDAZOLE 10 % Vaginal Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 247057 | methotrimeprazine 5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247058 | methotrimeprazine 40 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247059 | periciazine 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247059 | periciazine 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247060 | periciazine 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247060 | periciazine 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247061 | periciazine 10 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247066 | piroxicam 10 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247066 | piroxicam 10 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247069 | indomethacin 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247069 | indomethacin 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247069 | indomethacin 1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247070 | betamethasone 0.05 MG/ML Enema | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247071 | erythromycin 0.04 MG/MG / tretinoin 0.00025 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247072 | beclomethasone 0.25 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247073 | flumethasone pivalate 0.03 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247073 | flumethasone pivalate 0.03 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247073 | flumethasone pivalate 0.03 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247074 | aluminum acetate 3.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247075 | Carbachol 250 microgram/mL solution for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247075 | Carbachol 250 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 247075 | Carbachol 250 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 247076 | indomethacin 10 MG/ML Ophthalmic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247079 | shark liver oil 0.03 MG/MG / tissue respiratory factor 2000 UNT Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247086 | amylase 58,500 UNT / lipase 18,000 UNT / protease 58,500 UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247086 | amylase 58,500 UNT / lipase 18,000 UNT / protease 58,500 UNT Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 247086 | amylase 58,500 UNT / lipase 18,000 UNT / protease 58,500 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247086 | amylase 58,500 UNT / lipase 18,000 UNT / protease 58,500 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247086 | amylase 58,500 UNT / lipase 18,000 UNT / protease 58,500 UNT Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2470932 | benzalkonium chloride 0.05 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2470932 | benzalkonium chloride 0.05 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2470932 | benzalkonium chloride 0.05 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2470934 | imidacloprid 100 MG/ML / moxidectin 10 MG/ML [Imoxi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2470935 | IMOXI 10 % / 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2470935 | IMOXI 10 % / 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2470935 | IMOXI 10 % / 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247094 | allyl sulfide 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247096 | coal tar 10 % / salicylic acid 6 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247096 | coal tar 10 % / salicylic acid 6 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24710 | Complement factor Bb | Designated preferred name (PT) | NO | |
| RxCUI: 24710 | Complement factor Bb | Full form of descriptor (FN) | NO | |
| RxCUI: 247105 | guaiFENesin 50 MG / phenylpropanolamine HCl 6.25 MG per 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247105 | guaiFENesin 50 MG / phenylpropanolamine HCl 6.25 MG per 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 247105 | guaiFENesin 50 MG / phenylpropanolamine HCl 6.25 MG per 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247105 | guaiFENesin 50 MG / phenylpropanolamine HCl 6.25 MG per 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247105 | guaiFENesin 50 MG / phenylpropanolamine HCl 6.25 MG per 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2471077 | Acer saccharum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471078 | tirbanibulin | Full form of descriptor (FN) | YES | |
| RxCUI: 2471078 | tirbanibulin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2471078 | tirbanibulin | Designated preferred name (PT) | YES | |
| RxCUI: 2471078 | tirbanibulin | Full form of descriptor (FN) | YES | |
| RxCUI: 2471078 | tirbanibulin | Designated preferred name (PT) | YES | |
| RxCUI: 2471079 | 1,1-diphenylurea | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471080 | amodimethicone (240 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471082 | bovine type II collagen (tracheal cartilage) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2471083 | Collagen type II | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471083 | Collagen type II | Designated preferred name (PT) | NO | |
| RxCUI: 2471083 | Collagen type II | Full form of descriptor (FN) | NO | |
| RxCUI: 2471084 | Callitris columellaris wood oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471085 | propylene glycol t-butyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471086 | pyrroloquinolinedione tricarboxylic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471087 | surfactant protein-D homotrimer, recombinant fragment human | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2471088 | surfactant protein-D homotrimer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471089 | sodium chloride dihyrdate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2471090 | sodium laureth-6 carboxylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2471091 | laureth-6 carboxylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471092 | tirbanibulin 0.01 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2471093 | tirbanibulin Topical Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2471093 | tirbanibulin Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2471093 | tirbanibulin Topical Product | Designated preferred name (PT) | YES | |
| RxCUI: 2471094 | tirbanibulin Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2471095 | tirbanibulin 1 % Topical Ointment | Full form of descriptor (FN) | YES | |
| RxCUI: 2471095 | tirbanibulin 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2471095 | tirbanibulin 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2471095 | tirbanibulin 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2471095 | tirbanibulin 1 % Topical Ointment | Designated preferred name (PT) | YES | |
| RxCUI: 2471096 | Klisyri | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2471097 | tirbanibulin 0.01 MG/MG [Klisyri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2471098 | tirbanibulin Topical Ointment [Klisyri] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2471099 | Klisyri Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2471100 | Klisyri 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2471100 | Klisyri 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2471100 | Klisyri 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2471100 | Klisyri 1 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2471105 | adapalene / benzoyl peroxide Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2471106 | adapalene / benzoyl peroxide Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2471107 | adapalene 0.1 % / benzoyl peroxide 2.5 % Swab | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2471107 | adapalene 0.1 % / benzoyl peroxide 2.5 % Swab | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2471107 | adapalene 0.1 % / benzoyl peroxide 2.5 % Swab | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 247122 | nilutamide 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247122 | nilutamide 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247123 | sucralfate 200 MG/mL Oral Suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 247123 | sucralfate 200 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247123 | sucralfate 200 MG/mL Oral Suspension | Designated preferred name (PT) | NO | |
| RxCUI: 247123 | sucralfate 200 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247127 | iron sorbitex 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247128 | pipemidic acid 400 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247129 | phenolphthalein 100 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2471302 | .beta.-amyloid protein-(1-6)-peptidylglycylglycyl-L-cysteine-3-(2,5-dioxo-2,5-dihydro-1H-pyrrole-1-yl)-n-(6-((2,5-dioxopyrrolidin-1-yl)oxy)-6-oxohexyl)propanamide-alanine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471303 | triethoxysilylpropyl steardimonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471304 | octadecyl di-tert-butyl-4-hydroxyhydrocinnamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471306 | ethanol 94 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2471306 | ethanol 94 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2471306 | ethanol 94 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2471310 | sodium monofluorophosphate 0.0072 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2471311 | sodium monofluorophosphate 0.72 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2471311 | sodium monofluorophosphate 0.72 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2471311 | sodium monofluorophosphate 0.72 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2471314 | Tri-Nymyo 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2471314 | Tri-Nymyo 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2471314 | Tri-Nymyo 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247137 | aspirin 650 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247137 | aspirin 650 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247137 | aspirin 650 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247138 | ASA 850 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247138 | ASA 850 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247139 | sulfur 8 % / resorcinol 2 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247139 | sulfur 8 % / resorcinol 2 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 247139 | sulfur 8 % / resorcinol 2 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 247140 | coal tar 20 MG/ML / salicylic acid 30 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2471402 | petrolatum 0.99 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2471403 | petrolatum 99 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2471403 | petrolatum 99 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2471403 | petrolatum 99 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2471404 | menthol 10.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2471404 | menthol 10.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2471404 | menthol 10.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2471430 | Lactobacillus fermentum | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2471430 | Lactobacillus fermentum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2471431 | ocean perch preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471432 | ethanol 94 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2471432 | ethanol 94 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2471432 | ethanol 94 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247145 | benzocaine 5 % / tannic acid 6 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247145 | benzocaine 5 % / tannic acid 6 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247145 | benzocaine 5 % / tannic acid 6 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247147 | piperonyl butoxide 2.2 % / pyrethrins 0.18 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247147 | piperonyl butoxide 2.2 % / pyrethrins 0.18 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247147 | piperonyl butoxide 2.2 % / pyrethrins 0.18 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247149 | pancreatin 300 MG / pepsin A 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247153 | calcium carbonate 311 MG / magnesium carbonate 232 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247161 | mesalamine 250 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247161 | mesalamine 250 MG Rectal Suppository | Designated preferred name (PT) | NO | |
| RxCUI: 247161 | mesalamine 250 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247161 | mesalamine 250 MG Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247161 | mesalamine 250 MG Rectal Suppository | Full form of descriptor (FN) | NO | |
| RxCUI: 2471704 | Rattus norvegicus hair preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471705 | glycerin 1,3-dimethyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471867 | hydroxyethyl palmityl oxyhydroxypropyl palmitamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471868 | Rosa X alba flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471869 | sodium linoleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2471870 | Inula helnium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2471871 | betamethasone dipropionate 0.64 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2471872 | betamethasone / calcipotriene Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2471873 | betamethasone dipropionate 0.064 % / calcipotriene 0.005 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2471873 | betamethasone dipropionate 0.064 % / calcipotriene 0.005 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2471873 | betamethasone dipropionate 0.064 % / calcipotriene 0.005 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2471874 | Wynzora | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2471875 | betamethasone dipropionate 0.64 MG/ML / calcipotriene 0.05 MG/ML [Wynzora] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2471876 | betamethasone / calcipotriene Topical Cream [Wynzora] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2471877 | Wynzora Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2471878 | Wynzora 0.005 % / 0.064 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2471878 | Wynzora 0.005 % / 0.064 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2471878 | Wynzora 0.005 % / 0.064 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2471879 | lasmiditan 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2471880 | lasmiditan 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2471880 | lasmiditan 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2471881 | lasmiditan 200 MG [Reyvow] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2471882 | Reyvow 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2471882 | Reyvow 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2471882 | Reyvow 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2471883 | Gleptosil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2471884 | iron-dextran complex 200 MG/ML [Gleptosil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2471885 | iron-dextran complex Injectable Solution [Gleptosil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2471886 | Gleptosil Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2471887 | Gleptosil 200 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2471887 | Gleptosil 200 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2471887 | Gleptosil 200 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2471888 | Ursoferran | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2471889 | iron-dextran complex 200 MG/ML [Ursoferran] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2471890 | iron-dextran complex Injectable Solution [Ursoferran] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2471891 | Ursoferran Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2471892 | Ursoferran 200 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2471892 | Ursoferran 200 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2471892 | Ursoferran 200 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2471955 | lidocaine hydrochloride 4 % / menthol 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2471955 | lidocaine hydrochloride 4 % / menthol 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2471955 | lidocaine hydrochloride 4 % / menthol 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2471957 | benzocaine / povidone-iodine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2472 | Chondroitin sulfate lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2472 | Chondroitin sulfate lyase | Designated preferred name (PT) | NO | |
| RxCUI: 2472 | Chondroitin sulfate lyase | Full form of descriptor (FN) | NO | |
| RxCUI: 2472 | Chondroitin sulfate lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2472 | Chondroitin sulfate lyase | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2472102 | ethanol 0.723 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2472103 | ethanol 72.34 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2472103 | ethanol 72.34 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2472103 | ethanol 72.34 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2472149 | hydrogen peroxide 38 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2472150 | hydrogen peroxide 3.8 % Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2472150 | hydrogen peroxide 3.8 % Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2472150 | hydrogen peroxide 3.8 % Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2472151 | ansuvimab-zykl | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2472152 | ansuvimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2472152 | ansuvimab | Designated preferred name (PT) | YES | |
| RxCUI: 2472152 | ansuvimab | Full form of descriptor (FN) | YES | |
| RxCUI: 2472152 | ansuvimab | Designated preferred name (PT) | YES | |
| RxCUI: 2472152 | ansuvimab | Full form of descriptor (FN) | YES | |
| RxCUI: 2472153 | ansuvimab-zykl 400 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2472154 | ansuvimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2472154 | ansuvimab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2472154 | ansuvimab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2472155 | ansuvimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2472156 | ansuvimab-zykl 400 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2472156 | ansuvimab-zykl 400 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2472157 | Ebanga | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2472158 | ansuvimab-zykl 400 MG [Ebanga] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2472159 | ansuvimab Injection [Ebanga] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2472160 | Ebanga Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2472161 | ebanga 400 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2472161 | ebanga 400 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2472161 | ebanga 400 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2472162 | povidone-iodine 0.07 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2472163 | benzocaine 5 % / povidone-iodine 7 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2472163 | benzocaine 5 % / povidone-iodine 7 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2472163 | benzocaine 5 % / povidone-iodine 7 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2472164 | benzocaine / povidone-iodine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2472165 | benzocaine / povidone-iodine Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2472167 | iodine 10 MG/ML [Dairyland Brand Controlled Iodine Teat Dip] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2472169 | urea 200 MG/ML [Carmol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2472170 | urea Topical Cream [Carmol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2472172 | urea 0.4 MG/MG [Carmol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2472173 | urea Topical Gel [Carmol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2472175 | urea 400 MG/ML [Carmol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 247218 | 12 HR guaifenesin 0.00667 MG/MG / theophylline 0.02 MG/MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247218 | 12 HR guaifenesin 0.00667 MG/MG / theophylline 0.02 MG/MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2472186 | heptane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2472254 | vibegron | Full form of descriptor (FN) | YES | |
| RxCUI: 2472254 | vibegron | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2472254 | vibegron | Designated preferred name (PT) | YES | |
| RxCUI: 2472254 | vibegron | Full form of descriptor (FN) | YES | |
| RxCUI: 2472254 | vibegron | Designated preferred name (PT) | YES | |
| RxCUI: 2472307 | Dolishale 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2472307 | Dolishale 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2472307 | Dolishale 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2472310 | cinidon-ethyl | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2472311 | vibegron 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2472312 | vibegron Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2472312 | vibegron Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2472312 | vibegron Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2472313 | vibegron Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2472314 | vibegron Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2472315 | vibegron 75 MG Once-Daily Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2472315 | vibegron 75 MG Once-Daily Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2472315 | vibegron 75 MG Once-Daily Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2472315 | vibegron 75 MG Once-Daily Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2472316 | Gemtesa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2472317 | vibegron 75 MG [Gemtesa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2472318 | vibegron Oral Tablet [Gemtesa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2472319 | Gemtesa Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2472320 | Gemtesa Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2472321 | GEMTESA 75 MG Once-Daily Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2472321 | GEMTESA 75 MG Once-Daily Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2472321 | GEMTESA 75 MG Once-Daily Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2472322 | Triethyleneglycol dimethacrylate | Full form of descriptor (FN) | NO | |
| RxCUI: 2472322 | Triethyleneglycol dimethacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2472322 | Triethyleneglycol dimethacrylate | Designated preferred name (PT) | NO | |
| RxCUI: 2472322 | Triethyleneglycol dimethacrylate | Full form of descriptor (FN) | NO | |
| RxCUI: 2472322 | Triethyleneglycol dimethacrylate | Designated preferred name (PT) | NO | |
| RxCUI: 2472323 | cholecalciferol 0.625 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2472324 | cholecalciferol 0.625 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2472324 | cholecalciferol 0.625 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2472324 | cholecalciferol 0.625 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2472325 | rituximab-arrx | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2472325 | rituximab-arrx | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2472326 | rituximab-arrx 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2472326 | rituximab-arrx 10 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2472327 | riTUXimab-arrx 100 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2472327 | riTUXimab-arrx 100 MG in 10 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2472327 | riTUXimab-arrx 100 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2472327 | riTUXimab-arrx 100 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2472327 | riTUXimab-arrx 100 MG in 10 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2472328 | Riabni | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2472329 | rituximab-arrx 10 MG/ML [Riabni] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2472329 | rituximab-arrx 10 MG/ML [Riabni] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2472330 | rituximab Injection [Riabni] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2472330 | rituximab Injection [Riabni] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2472331 | Riabni Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2472332 | RIABNI 100 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2472332 | RIABNI 100 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2472332 | RIABNI 100 MG in 10 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2472332 | RIABNI 100 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2472332 | RIABNI 100 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2472333 | rituximab-arrx 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2472333 | rituximab-arrx 10 MG/ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2472334 | rituximab-arrx 10 MG/ML Injection [Riabni] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2472334 | rituximab-arrx 10 MG/ML Injection [Riabni] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2472334 | rituximab-arrx 10 MG/ML Injection [Riabni] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2472335 | riTUXimab-arrx 500 MG in 50 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2472335 | riTUXimab-arrx 500 MG in 50 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2472335 | riTUXimab-arrx 500 MG in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2472335 | riTUXimab-arrx 500 MG in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2472335 | riTUXimab-arrx 500 MG in 50 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2472336 | RIABNI 500 MG in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2472336 | RIABNI 500 MG in 50 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2472336 | RIABNI 500 MG in 50 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2472336 | RIABNI 500 MG in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2472336 | RIABNI 500 MG in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2472338 | diphenhydramine hydrochloride 10 MG/ML / zinc acetate 1 MG/ML [Wal-Dryl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2472338 | diphenhydramine hydrochloride 10 MG/ML / zinc acetate 1 MG/ML [Wal-Dryl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2472339 | Wal-Dryl 1 % / 0.1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2472339 | Wal-Dryl 1 % / 0.1 % Topical Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2472339 | Wal-Dryl 1 % / 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2472339 | Wal-Dryl 1 % / 0.1 % Topical Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2472339 | Wal-Dryl 1 % / 0.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2472364 | carboxymethylcellulose 1.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2472365 | carboxymethylcellulose Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2472366 | carboxymethylcellulose Medicated Patch | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2472367 | carboxymethylcellulose 1.5 MG Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2472367 | carboxymethylcellulose 1.5 MG Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24724 | Coagulation factor V antigen | Designated preferred name (PT) | NO | |
| RxCUI: 24724 | Coagulation factor V antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 247252 | hydrogen peroxide 1.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247252 | hydrogen peroxide 1.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247252 | hydrogen peroxide 1.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24726 | Coagulation factor VII antigen | Designated preferred name (PT) | NO | |
| RxCUI: 24726 | Coagulation factor VII antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 2472775 | .alpha.-citronellal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2472776 | stearyl acrylate polymer (110000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2472777 | Ipomoea batatas whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2472778 | relugolix | Full form of descriptor (FN) | YES | |
| RxCUI: 2472778 | relugolix | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2472778 | relugolix | Designated preferred name (PT) | YES | |
| RxCUI: 2472778 | relugolix | Full form of descriptor (FN) | YES | |
| RxCUI: 2472778 | relugolix | Designated preferred name (PT) | YES | |
| RxCUI: 2472779 | relugolix 120 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2472780 | relugolix Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2472780 | relugolix Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2472780 | relugolix Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2472781 | relugolix Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2472782 | relugolix Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2472783 | relugolix 120 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2472783 | relugolix 120 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2472783 | relugolix 120 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2472783 | relugolix 120 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2472784 | Orgovyx | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2472785 | relugolix 120 MG [Orgovyx] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2472786 | relugolix Oral Tablet [Orgovyx] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2472787 | Orgovyx Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2472788 | Orgovyx Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2472789 | ORGOVYX 120 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2472789 | ORGOVYX 120 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2472789 | ORGOVYX 120 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2472790 | trastuzumab-qyyp 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2472791 | trastuzumab-qyyp 150 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2472791 | trastuzumab-qyyp 150 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2472792 | trastuzumab-qyyp 150 MG [Trazimera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2472793 | trastuzumab Injection [Trazimera] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2472794 | Trazimera 150 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2472794 | Trazimera 150 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2472794 | Trazimera 150 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2472795 | polyoxyl 15 hydroxystearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2472898 | Imidazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2472898 | Imidazole | Designated preferred name (PT) | NO | |
| RxCUI: 2472898 | Imidazole | Full form of descriptor (FN) | NO | |
| RxCUI: 2472898 | Imidazole | Designated preferred name (PT) | NO | |
| RxCUI: 2472898 | Imidazole | Full form of descriptor (FN) | NO | |
| RxCUI: 247293 | dexamethasone 3.2 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247293 | dexamethasone 3.2 MG/ML Injectable Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 247294 | benzocaine 7.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247294 | benzocaine 7.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247294 | benzocaine 7.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2473 | Chondroitin sulfate | Designated preferred name (PT) | YES | |
| RxCUI: 2473 | Chondroitin sulfate | Full form of descriptor (FN) | YES | |
| RxCUI: 2473 | Chondroitin sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2473 | Chondroitin sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| RxCUI: 2473039 | ponatinib 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2473039 | ponatinib 10 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2473040 | PONATinib 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2473040 | PONATinib 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2473040 | PONATinib 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2473040 | PONATinib 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2473040 | PONATinib 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2473041 | ponatinib 10 MG [Iclusig] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2473041 | ponatinib 10 MG [Iclusig] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2473042 | Iclusig 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2473042 | Iclusig 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2473042 | Iclusig 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2473042 | Iclusig 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 247305 | caffeine 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247308 | benzyl alcohol 10 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247308 | benzyl alcohol 10 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247308 | benzyl alcohol 10 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2473106 | isotretinoin 30 MG [Accutane] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2473106 | isotretinoin 30 MG [Accutane] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2473107 | ACCUTANE 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2473107 | ACCUTANE 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2473107 | ACCUTANE 30 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2473107 | ACCUTANE 30 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 247313 | tolnaftate 1 % / triacetin 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247313 | tolnaftate 1 % / triacetin 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247313 | tolnaftate 1 % / triacetin 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2473230 | paclitaxel poliglumex | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2473230 | paclitaxel poliglumex | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2473231 | Solidago velutina whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 247324 | acetaminophen 500 MG /dextromethorphan HBr 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 247324 | acetaminophen 500 MG /dextromethorphan HBr 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 247324 | acetaminophen 500 MG /dextromethorphan HBr 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247324 | acetaminophen 500 MG /dextromethorphan HBr 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2473276 | levothyroxine sodium 100 MCG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2473276 | levothyroxine sodium 100 MCG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2473276 | levothyroxine sodium 100 MCG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2473276 | levothyroxine sodium 100 MCG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2473276 | levothyroxine sodium 100 MCG in 5 mL Oral Solution | Designated preferred name (PT) | YES | |
| RxCUI: 2473276 | levothyroxine sodium 100 MCG in 5 mL Oral Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 2473277 | Thyquidity | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2473278 | levothyroxine sodium 0.02 MG/ML [Thyquidity] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2473279 | levothyroxine Oral Solution [Thyquidity] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2473280 | Thyquidity Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2473281 | Thyquidity Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2473282 | Thyquidity 100 MCG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2473282 | Thyquidity 100 MCG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2473282 | Thyquidity 100 MCG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2473282 | Thyquidity 100 MCG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2473282 | Thyquidity 100 MCG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2473283 | glucose 15000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2473284 | glucose 15 GM Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2473284 | glucose 15 GM Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2473284 | glucose 15 GM Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247330 | amylase 750 UNT / lipase 350 UNT / protease 3750 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247333 | chromium picolinate 1.67 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247334 | piperonyl butoxide 10 MG/ML / pyrethrins 2 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2473372 | camphor 5.9 % / menthol 0.8 % / methyl salicylate 4.6 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2473372 | camphor 5.9 % / menthol 0.8 % / methyl salicylate 4.6 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2473372 | camphor 5.9 % / menthol 0.8 % / methyl salicylate 4.6 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2473373 | camphor 2 % / lidocaine 4 % / methyl salicylate 4 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2473373 | camphor 2 % / lidocaine 4 % / methyl salicylate 4 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2473373 | camphor 2 % / lidocaine 4 % / methyl salicylate 4 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2473374 | 1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol 2000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2473375 | alpha, alpha'-diglycerol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2473379 | ethanol 80 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2473379 | ethanol 80 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2473379 | ethanol 80 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2473383 | glycopyrrolate 0.6 MG in 3 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2473383 | glycopyrrolate 0.6 MG in 3 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2473383 | glycopyrrolate 0.6 MG in 3 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2473384 | Glyrx-PF 0.6 MG in 3 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2473384 | Glyrx-PF 0.6 MG in 3 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2473384 | Glyrx-PF 0.6 MG in 3 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2473384 | Glyrx-PF 0.6 MG in 3 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247340 | dihydroxyacetone 6.55 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247340 | dihydroxyacetone 6.55 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247340 | dihydroxyacetone 6.55 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2473417 | camphor 3 % / menthol 2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2473417 | camphor 3 % / menthol 2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2473417 | camphor 3 % / menthol 2 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24735 | Flavin-adenine dinucleotide (FAD) pyrophosphatase | Designated preferred name (PT) | NO | |
| RxCUI: 24735 | Flavin-adenine dinucleotide (FAD) pyrophosphatase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 24735 | Flavin-adenine dinucleotide (FAD) pyrophosphatase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 24735 | Flavin-adenine dinucleotide (FAD) pyrophosphatase | Full form of descriptor (FN) | NO | |
| RxCUI: 247350 | gentamicin (as gentamicin sulfate) 0.3 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247350 | gentamicin (as gentamicin sulfate) 0.3 % Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247352 | hydrocortisone 0.0075 MG/MG Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247355 | pilocarpine 2 % / timolol 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247355 | pilocarpine 2 % / timolol 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247355 | pilocarpine 2 % / timolol 0.5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247356 | pilocarpine 4 % / timolol 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247356 | pilocarpine 4 % / timolol 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247356 | pilocarpine 4 % / timolol 0.5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247363 | periciazine 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247363 | periciazine 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247365 | calcium ascorbate 850 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247366 | carboxymethylcellulose 300 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247368 | thiopropazate 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247372 | ASA 325 MG / Codeine 8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247372 | ASA 325 MG / Codeine 8 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247375 | alloin 15 MG / phenolphthalein 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247376 | alloin 8 MG / phenolphthalein 16 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2473841 | dimethyltetradecyl(3-(trimethoxysilyl)propyl)ammonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2473844 | ethanethioic acid, S-(1-((1E)-2-hydroxyethenyl)butyl) ester | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2473847 | ethanol 0.91 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2473848 | ethanol 91 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2473848 | ethanol 91 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2473848 | ethanol 91 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2473850 | margetuximab-cmkb | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2473851 | margetuximab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2473851 | margetuximab | Designated preferred name (PT) | YES | |
| RxCUI: 2473851 | margetuximab | Full form of descriptor (FN) | YES | |
| RxCUI: 2473851 | margetuximab | Designated preferred name (PT) | YES | |
| RxCUI: 2473851 | margetuximab | Full form of descriptor (FN) | YES | |
| RxCUI: 247390 | calcium gluceptate 132 MG/ML / calcium gluconate 112 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247392 | chloroxylenol 100 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247393 | chloroxylenol 50 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247394 | chloroxylenol 0.25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247394 | chloroxylenol 0.25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247394 | chloroxylenol 0.25 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247395 | chloroxylenol 6 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247396 | chloroxylenol 3 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 247396 | chloroxylenol 3 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247396 | chloroxylenol 3 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 247399 | 4-cresyl acetate 1000 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247400 | cresol 12.5 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2474006 | olopatadine 7 MG/ML [Pataday] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2474007 | Pataday 0.7 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2474007 | Pataday 0.7 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2474007 | Pataday 0.7 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247402 | isopropyl alcohol 90 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 247402 | isopropyl alcohol 90 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 247402 | isopropyl alcohol 90 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474025 | margetuximab-cmkb 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2474026 | margetuximab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2474026 | margetuximab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2474026 | margetuximab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2474027 | margetuximab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2474028 | margetuximab-cmkb 250 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2474028 | margetuximab-cmkb 250 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2474028 | margetuximab-cmkb 250 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474029 | Margenza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2474030 | margetuximab-cmkb 25 MG/ML [Margenza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2474031 | margetuximab Injection [Margenza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2474032 | Margenza Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2474033 | Margenza 250 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474033 | Margenza 250 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2474033 | Margenza 250 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2474033 | Margenza 250 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474034 | margetuximab-cmkb 25 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2474035 | margetuximab-cmkb 25 MG/ML Injection [Margenza] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2474035 | margetuximab-cmkb 25 MG/ML Injection [Margenza] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2474038 | Mentha suaveolens leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2474039 | naxitamab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2474039 | naxitamab | Designated preferred name (PT) | YES | |
| RxCUI: 2474039 | naxitamab | Full form of descriptor (FN) | YES | |
| RxCUI: 2474039 | naxitamab | Designated preferred name (PT) | YES | |
| RxCUI: 2474039 | naxitamab | Full form of descriptor (FN) | YES | |
| RxCUI: 247404 | magnesium sulfate 137 MG/ML / peptones 30 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247405 | sodium selenite 0.04 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247410 | paregoric 0.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247418 | betamethasone 1 MG/ML / sulfacetamide 100 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247419 | chloramphenicol 2 MG/ML / hydrocortisone 10 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247423 | normethadone 10 MG/ML / oxilofrine 20 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2474235 | naxitamab-gqgk | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2474236 | naxitamab-gqgk 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2474237 | naxitamab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2474237 | naxitamab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2474237 | naxitamab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2474238 | naxitamab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2474239 | naxitamab-gqgk 40 MG per 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2474239 | naxitamab-gqgk 40 MG per 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2474239 | naxitamab-gqgk 40 MG per 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474240 | Danyelza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2474241 | naxitamab-gqgk 4 MG/ML [Danyelza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2474242 | naxitamab Injection [Danyelza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2474243 | Danyelza Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2474244 | DANYELZA 40 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474244 | DANYELZA 40 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2474244 | DANYELZA 40 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2474244 | DANYELZA 40 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474245 | naxitamab-gqgk 4 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2474246 | naxitamab-gqgk 4 MG/ML Injection [Danyelza] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2474246 | naxitamab-gqgk 4 MG/ML Injection [Danyelza] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2474262 | oxymetazoline hydrochloride 0.0005 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2474263 | oxymetazoline Nasal Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2474264 | oxymetazoline hydrochloride 0.05 % Nasal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474264 | oxymetazoline hydrochloride 0.05 % Nasal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2474264 | oxymetazoline hydrochloride 0.05 % Nasal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2474266 | fentanyl Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2474266 | fentanyl Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2474267 | fentaNYL 100 MCG in 2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2474267 | fentaNYL 100 MCG in 2 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2474267 | fentaNYL 100 MCG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474267 | fentaNYL 100 MCG in 2 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2474267 | fentaNYL 100 MCG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2474267 | fentaNYL 100 MCG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474267 | fentaNYL 100 MCG in 2 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2474268 | fentanyl 0.05 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2474268 | fentanyl 0.05 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2474269 | fentaNYL 0.05 MG in1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2474269 | fentaNYL 0.05 MG in1 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2474269 | fentaNYL 0.05 MG in1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474269 | fentaNYL 0.05 MG in1 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2474269 | fentaNYL 0.05 MG in1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2474269 | fentaNYL 0.05 MG in1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474269 | fentaNYL 0.05 MG in1 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 247428 | magnesium sulfate 400 MG/ML / peptones 80 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247429 | benzalkonium 1.4 MG/ML / lidocaine 26 MG/ML Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247430 | benzethonium 1.5 MG/ML / benzocaine 45 MG/ML Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247432 | ZNO 125 MG/ML Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247432 | ZNO 125 MG/ML Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2474330 | citric acid 1530 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2474331 | sodium bicarbonate 2210 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2474332 | citric acid / simethicone / sodium bicarbonate Granules for Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2474333 | citric acid 1.53 GM / simethicone 0.04 GM / sodium bicarbonate 2.21 GM Effervescent Granules for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2474333 | citric acid 1.53 GM / simethicone 0.04 GM / sodium bicarbonate 2.21 GM Effervescent Granules for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474333 | citric acid 1.53 GM / simethicone 0.04 GM / sodium bicarbonate 2.21 GM Effervescent Granules for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474333 | citric acid 1.53 GM / simethicone 0.04 GM / sodium bicarbonate 2.21 GM Effervescent Granules for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2474334 | E-Z-Gas II | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2474335 | citric acid 1530 MG / simethicone 40 MG / sodium bicarbonate 2210 MG [E-Z-Gas II] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2474336 | citric acid / simethicone / sodium bicarbonate Granules for Oral Solution [E-Z-Gas II] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2474337 | E-Z-Gas II Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2474338 | E-Z-Gas II Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2474339 | E-Z-Gas II 1.53 GM / 0.04 GM / 2.21 GM Effervescent Granules for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474339 | E-Z-Gas II 1.53 GM / 0.04 GM / 2.21 GM Effervescent Granules for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2474339 | E-Z-Gas II 1.53 GM / 0.04 GM / 2.21 GM Effervescent Granules for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2474340 | Clascoterone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2474340 | Clascoterone | Designated preferred name (PT) | YES | |
| RxCUI: 2474340 | Clascoterone | Full form of descriptor (FN) | YES | |
| RxCUI: 2474340 | Clascoterone | Designated preferred name (PT) | YES | |
| RxCUI: 2474340 | Clascoterone | Full form of descriptor (FN) | YES | |
| RxCUI: 2474344 | clascoterone 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2474344 | clascoterone 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474344 | clascoterone 1 % Topical Cream | Designated preferred name (PT) | YES | |
| RxCUI: 2474344 | clascoterone 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2474344 | clascoterone 1 % Topical Cream | Full form of descriptor (FN) | YES | |
| RxCUI: 2474345 | Winlevi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2474348 | Winlevi Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2474349 | Winlevi 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2474349 | Winlevi 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2474349 | Winlevi 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474349 | Winlevi 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247435 | beclomethasone 0.25 MG/ML / clioquinol 30 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247436 | betamethasone 1 MG/ML / neomycin 3.5 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247442 | betamethasone 1 MG/ML / neomycin 3.5 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247443 | betamethasone 0.5 MG/ML / salicylic acid 20 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2474485 | Lydexa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2474486 | lidocaine hydrochloride 41.2 MG/ML [Lydexa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2474487 | lidocaine Topical Cream [Lydexa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2474488 | Lydexa Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2474489 | Lydexa 4.12 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2474489 | Lydexa 4.12 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2474489 | Lydexa 4.12 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474489 | Lydexa 4.12 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247449 | beclomethasone 0.00025 MG/MG / clioquinol 0.03 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2474490 | camphor 40 MG/ML / menthol 75 MG/ML / methyl salicylate 100 MG/ML [Apeaz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2474491 | Apeaz Ultra 4 % / 7.5 % / 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2474491 | Apeaz Ultra 4 % / 7.5 % / 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2474491 | Apeaz Ultra 4 % / 7.5 % / 10 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2474494 | acetaminophen / aspirin / caffeine Effervescent Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2474495 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Effervescent Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2474495 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Effervescent Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2474495 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Effervescent Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2474497 | Indacaterol acetate | Designated preferred name (PT) | NO | |
| RxCUI: 2474497 | Indacaterol acetate | Full form of descriptor (FN) | NO | |
| RxCUI: 247450 | betamethasone 0.001 MG/MG / neomycin 0.0035 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2474502 | glucose Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2474503 | glucose Powder for Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2474504 | glucose 15 GM Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2474504 | glucose 15 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2474504 | glucose 15 GM Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 247451 | betamethasone 0.05 % / salicylic acid 3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247451 | betamethasone 0.05 % / salicylic acid 3 % Topical Ointment | Designated preferred name (PT) | NO | |
| RxCUI: 247451 | betamethasone 0.05 % / salicylic acid 3 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247451 | betamethasone 0.05 % / salicylic acid 3 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247451 | betamethasone 0.05 % / salicylic acid 3 % Topical Ointment | Full form of descriptor (FN) | NO | |
| RxCUI: 247452 | Chloramphenicol 1 % / Hydrocortisone 1 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247452 | Chloramphenicol 1 % / Hydrocortisone 1 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247463 | hexylresorcinol 2.4 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 247463 | hexylresorcinol 2.4 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 247463 | hexylresorcinol 2.4 MG Oral Lozenge | Designated preferred name (PT) | YES | |
| RxCUI: 247463 | hexylresorcinol 2.4 MG Oral Lozenge | Full form of descriptor (FN) | YES | |
| RxCUI: 2474630 | 1,1,1-triethoxyethane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2474631 | PEG-4 caprylic-capric glycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2474632 | Dodecafluoropentane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2474632 | Dodecafluoropentane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2474632 | Dodecafluoropentane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2474632 | Dodecafluoropentane | Designated preferred name (PT) | NO | |
| RxCUI: 2474632 | Dodecafluoropentane | Full form of descriptor (FN) | NO | |
| RxCUI: 2474632 | Dodecafluoropentane | Designated preferred name (PT) | NO | |
| RxCUI: 2474632 | Dodecafluoropentane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2474632 | Dodecafluoropentane | Full form of descriptor (FN) | NO | |
| RxCUI: 2474633 | silane, triethenylmethyl- | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2474633 | silane, triethenylmethyl- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2474634 | lidocaine Rectal Suppository | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2474635 | lidocaine 50 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2474635 | lidocaine 50 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 247479 | betamethasone 1 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247480 | betamethasone 1 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247483 | milk of magnesia 385 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247483 | milk of magnesia 385 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247484 | dexAMETHasone 0.1 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247484 | dexAMETHasone 0.1 % Ophthalmic Ointment | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 247484 | dexAMETHasone 0.1 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247484 | dexAMETHasone 0.1 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247484 | dexAMETHasone 0.1 % Ophthalmic Ointment | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 247495 | buserelin 0.1 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247495 | buserelin 0.1 % Injectable Solution | Designated preferred name (PT) | NO | |
| RxCUI: 247495 | buserelin 0.1 % Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247495 | buserelin 0.1 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247495 | buserelin 0.1 % Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247495 | buserelin 0.1 % Injectable Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 24750 | Fansidar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2475073 | 1,3,5-triethylbenzene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2475074 | 3-(3-methyl-2-thienyl)acrylic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2475076 | cabotegravir sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2475076 | cabotegravir sodium | Designated preferred name (PT) | YES | |
| RxCUI: 2475076 | cabotegravir sodium | Full form of descriptor (FN) | YES | |
| RxCUI: 2475077 | cabotegravir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2475077 | cabotegravir | Designated preferred name (PT) | YES | |
| RxCUI: 2475077 | cabotegravir | Full form of descriptor (FN) | YES | |
| RxCUI: 2475077 | cabotegravir | Designated preferred name (PT) | YES | |
| RxCUI: 2475077 | cabotegravir | Full form of descriptor (FN) | YES | |
| RxCUI: 247508 | guaiFENesin 200 MG / phenylpropanolamine HCl 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247508 | guaiFENesin 200 MG / phenylpropanolamine HCl 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247508 | guaiFENesin 200 MG / phenylpropanolamine HCl 25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 247508 | guaiFENesin 200 MG / phenylpropanolamine HCl 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247508 | guaiFENesin 200 MG / phenylpropanolamine HCl 25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 247509 | Estrone 0.1 % Vaginal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247509 | Estrone 0.1 % Vaginal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247511 | Human isophane insulin 90 unit/mL and recombinant human soluble insulin 10 unit/mL suspension for injection | Designated preferred name (PT) | NO | |
| RxCUI: 247511 | Human isophane insulin 90 unit/mL and recombinant human soluble insulin 10 unit/mL suspension for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247511 | Human isophane insulin 90 unit/mL and recombinant human soluble insulin 10 unit/mL suspension for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247511 | Human isophane insulin 90 unit/mL and recombinant human soluble insulin 10 unit/mL suspension for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 247512 | Human isophane insulin 80 unit/mL and recombinant human soluble insulin 20 unit/mL suspension for injection | Designated preferred name (PT) | NO | |
| RxCUI: 247512 | Human isophane insulin 80 unit/mL and recombinant human soluble insulin 20 unit/mL suspension for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247512 | Human isophane insulin 80 unit/mL and recombinant human soluble insulin 20 unit/mL suspension for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247512 | Human isophane insulin 80 unit/mL and recombinant human soluble insulin 20 unit/mL suspension for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 247513 | Human isophane insulin 60 unit/mL and recombinant human soluble insulin 40 unit/mL suspension for injection | Designated preferred name (PT) | NO | |
| RxCUI: 247513 | Human isophane insulin 60 unit/mL and recombinant human soluble insulin 40 unit/mL suspension for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247513 | Human isophane insulin 60 unit/mL and recombinant human soluble insulin 40 unit/mL suspension for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247513 | Human isophane insulin 60 unit/mL and recombinant human soluble insulin 40 unit/mL suspension for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 247514 | PGE2 0.000333 MG/MG Vaginal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247514 | PGE2 0.000333 MG/MG Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247515 | PGE2 0.000667 MG/MG Vaginal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247515 | PGE2 0.000667 MG/MG Vaginal Gel | Designated preferred name (PT) | NO | |
| RxCUI: 247515 | PGE2 0.000667 MG/MG Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247515 | PGE2 0.000667 MG/MG Vaginal Gel | Full form of descriptor (FN) | NO | |
| RxCUI: 247516 | captopril 6.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247516 | captopril 6.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475165 | isopropyl alcohol 80 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475165 | isopropyl alcohol 80 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2475165 | isopropyl alcohol 80 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2475166 | voclosporin | Full form of descriptor (FN) | YES | |
| RxCUI: 2475166 | voclosporin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2475166 | voclosporin | Designated preferred name (PT) | YES | |
| RxCUI: 2475166 | voclosporin | Full form of descriptor (FN) | YES | |
| RxCUI: 2475166 | voclosporin | Designated preferred name (PT) | YES | |
| RxCUI: 2475167 | petrolatum 0.453 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2475168 | camphor 1.7 % / petrolatum, white 45.3 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475168 | camphor 1.7 % / petrolatum, white 45.3 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2475168 | camphor 1.7 % / petrolatum, white 45.3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247517 | promethazine 20 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475177 | Bifenthrin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2475177 | Bifenthrin | Designated preferred name (PT) | NO | |
| RxCUI: 2475177 | Bifenthrin | Full form of descriptor (FN) | NO | |
| RxCUI: 2475177 | Bifenthrin | Designated preferred name (PT) | NO | |
| RxCUI: 2475177 | Bifenthrin | Full form of descriptor (FN) | NO | |
| RxCUI: 2475178 | 1-phenylpropanol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475178 | 1-phenylpropanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2475179 | magnesium carbonate anhydrous | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2475179 | magnesium carbonate anhydrous | Designated preferred name (PT) | NO | |
| RxCUI: 2475179 | magnesium carbonate anhydrous | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2475179 | magnesium carbonate anhydrous | Full form of descriptor (FN) | NO | |
| RxCUI: 2475180 | sodium lauroyl glycinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2475182 | carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 2300 mpa.s at 1%) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2475185 | cellulase (Trichoderma longibrachiatum) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2475186 | monoethanolamine thioglycolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2475187 | Ginkgo biloba whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2475188 | carprofen 37.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2475189 | carprofen 37.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2475189 | carprofen 37.5 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475190 | carprofen 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2475191 | carprofen 50 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2475191 | carprofen 50 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475192 | pancreatic alpha-amylase | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2475193 | pancreatic triacylglycerol lipase | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2475195 | cabotegravir 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2475196 | cabotegravir Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2475196 | cabotegravir Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2475196 | cabotegravir Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2475197 | cabotegravir Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2475198 | cabotegravir Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2475199 | cabotegravir 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475199 | cabotegravir 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475199 | cabotegravir 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2475200 | Vocabria | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2475201 | cabotegravir 30 MG [Vocabria] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2475202 | cabotegravir Oral Tablet [Vocabria] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2475203 | Vocabria Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2475204 | Vocabria Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2475205 | VOCABRIA 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2475205 | VOCABRIA 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475205 | VOCABRIA 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475205 | VOCABRIA 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247522 | iodinated glycerol 12.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247531 | NaHCO3 460 MG/ML / tartaric acid 420 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247531 | NaHCO3 460 MG/ML / tartaric acid 420 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475332 | sodium starch glycolate type B | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2475336 | norepinephrine 0.016 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2475337 | norepinephrine bitartrate 4 MG in 250 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2475337 | norepinephrine bitartrate 4 MG in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475337 | norepinephrine bitartrate 4 MG in 250 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475338 | norepinephrine 0.016 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475339 | norepinephrine 0.032 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 247534 | magnesium gluconate 600 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475340 | norepinephrine bitartrate 8 MG in 250 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2475340 | norepinephrine bitartrate 8 MG in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475340 | norepinephrine bitartrate 8 MG in 250 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475341 | norepinephrine 0.032 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475349 | Bactine Wound Wash | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 247535 | magnesium gluconate 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475350 | benzalkonium chloride 1.3 MG/ML [Bactine Wound Wash] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2475351 | benzalkonium Topical Solution [Bactine Wound Wash] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2475352 | Bactine Wound Wash Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2475353 | Bactine Wound Wash 0.13 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475353 | Bactine Wound Wash 0.13 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475353 | Bactine Wound Wash 0.13 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475353 | Bactine Wound Wash 0.13 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2475356 | menthol 10 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475356 | menthol 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2475356 | menthol 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2475356 | menthol 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2475357 | menthol 0.1 MG/MG [Biofreeze] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2475358 | menthol Topical Ointment [Biofreeze] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2475359 | Biofreeze 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2475359 | Biofreeze 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2475359 | Biofreeze 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2475359 | Biofreeze 10 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2475360 | Lysosomal alpha-glucosidase | Designated preferred name (PT) | NO | |
| RxCUI: 2475360 | Lysosomal alpha-glucosidase | Full form of descriptor (FN) | NO | |
| RxCUI: 2475360 | Lysosomal alpha-glucosidase | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2475360 | Lysosomal alpha-glucosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2475361 | Alpha-glucosidase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2475361 | Alpha-glucosidase | Designated preferred name (PT) | NO | |
| RxCUI: 2475361 | Alpha-glucosidase | Full form of descriptor (FN) | NO | |
| RxCUI: 2475361 | Alpha-glucosidase | Designated preferred name (PT) | NO | |
| RxCUI: 2475361 | Alpha-glucosidase | Full form of descriptor (FN) | NO | |
| RxCUI: 247537 | allyl sulfide 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475396 | voclosporin 7.9 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2475397 | voclosporin Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2475397 | voclosporin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2475397 | voclosporin Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2475398 | voclosporin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2475399 | voclosporin Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 247540 | sennosides, USP 244 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475400 | voclosporin 7.9 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2475400 | voclosporin 7.9 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475400 | voclosporin 7.9 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2475400 | voclosporin 7.9 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2475401 | Lupkynis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2475402 | voclosporin 7.9 MG [Lupkynis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2475403 | voclosporin Oral Capsule [Lupkynis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2475404 | Lupkynis Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2475405 | Lupkynis Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2475406 | Lupkynis 7.9 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475406 | Lupkynis 7.9 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475406 | Lupkynis 7.9 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2475407 | cabotegravir 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2475408 | cabotegravir Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2475408 | cabotegravir Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2475408 | cabotegravir Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2475411 | rilpivirine 300 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2475412 | rilpivirine Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2475412 | rilpivirine Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2475412 | rilpivirine Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2475415 | cabotegravir 600 MG / rilpivirine 900 MG Extended Release Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2475415 | cabotegravir 600 MG / rilpivirine 900 MG Extended Release Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475415 | cabotegravir 600 MG / rilpivirine 900 MG Extended Release Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475416 | CABENUVA 600 MG / 900 MG Extended Release Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2475416 | CABENUVA 600 MG / 900 MG Extended Release Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475416 | CABENUVA 600 MG / 900 MG Extended Release Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475417 | cabotegravir 400 MG / rilpivirine 600 MG Extended Release Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2475417 | cabotegravir 400 MG / rilpivirine 600 MG Extended Release Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475417 | cabotegravir 400 MG / rilpivirine 600 MG Extended Release Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475418 | CABENUVA 400 MG / 600 MG Extended Release Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2475418 | CABENUVA 400 MG / 600 MG Extended Release Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475418 | CABENUVA 400 MG / 600 MG Extended Release Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247546 | allyl sulfide 341 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475473 | menthol 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2475473 | menthol 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2475473 | menthol 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247549 | chromium picolinate 1.6 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247551 | budesonide 32 MCG/ACTUAT Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247551 | budesonide 32 MCG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247551 | budesonide 32 MCG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247551 | budesonide 32 MCG/ACTUAT Nasal Spray | Designated preferred name (PT) | NO | |
| RxCUI: 247551 | budesonide 32 MCG/ACTUAT Nasal Spray | Full form of descriptor (FN) | NO | |
| RxCUI: 2475532 | Abametapir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2475532 | Abametapir | Designated preferred name (PT) | YES | |
| RxCUI: 2475532 | Abametapir | Full form of descriptor (FN) | YES | |
| RxCUI: 2475532 | Abametapir | Designated preferred name (PT) | YES | |
| RxCUI: 2475532 | Abametapir | Full form of descriptor (FN) | YES | |
| RxCUI: 2475536 | abametapir 0.74 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475536 | abametapir 0.74 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475536 | abametapir 0.74 % Topical Lotion | Designated preferred name (PT) | YES | |
| RxCUI: 2475536 | abametapir 0.74 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2475536 | abametapir 0.74 % Topical Lotion | Full form of descriptor (FN) | YES | |
| RxCUI: 2475537 | Xeglyze | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2475540 | Xeglyze Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2475541 | Xeglyze 0.74 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2475541 | Xeglyze 0.74 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475541 | Xeglyze 0.74 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475541 | Xeglyze 0.74 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247557 | amylase 180000 UNT / lipase 22500 UNT / protease 180000 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247558 | amylase 60000 UNT / lipase 12000 UNT / protease 60000 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247577 | dyphylline 60 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247578 | phenolphthalein 0.0142 MG/MG Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247580 | mineral oil 0.78 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247581 | attapulgite 60 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247582 | kaolin 200 MG/ML / pectin 4.76 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247583 | dimenhyDRINATE 100 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247583 | dimenhyDRINATE 100 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247583 | dimenhyDRINATE 100 MG Rectal Suppository | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2475830 | vericiguat | Full form of descriptor (FN) | YES | |
| RxCUI: 2475830 | vericiguat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2475830 | vericiguat | Designated preferred name (PT) | YES | |
| RxCUI: 2475830 | vericiguat | Full form of descriptor (FN) | YES | |
| RxCUI: 2475830 | vericiguat | Designated preferred name (PT) | YES | |
| RxCUI: 2475835 | mannitol 40 MG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475835 | mannitol 40 MG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2475836 | Bronchitol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2475839 | Bronchitol Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 247584 | dimenhyDRINATE 50 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247584 | dimenhyDRINATE 50 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247584 | dimenhyDRINATE 50 MG Rectal Suppository | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2475840 | Bronchitol 40 MG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475840 | Bronchitol 40 MG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475840 | Bronchitol 40 MG Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2475841 | ethanol 74 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475841 | ethanol 74 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2475841 | ethanol 74 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2475842 | vericiguat 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2475843 | vericiguat Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2475843 | vericiguat Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2475843 | vericiguat Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2475844 | vericiguat Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2475845 | vericiguat Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2475846 | vericiguat 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2475846 | vericiguat 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475846 | vericiguat 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2475846 | vericiguat 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2475847 | Verquvo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2475848 | vericiguat 10 MG [Verquvo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2475849 | vericiguat Oral Tablet [Verquvo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 247585 | dimenhyDRINATE 25 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247585 | dimenhyDRINATE 25 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247585 | dimenhyDRINATE 25 MG Rectal Suppository | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2475850 | Verquvo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2475851 | Verquvo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2475852 | Verquvo 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2475852 | Verquvo 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475852 | Verquvo 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475853 | vericiguat 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2475854 | vericiguat 2.5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2475854 | vericiguat 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475854 | vericiguat 2.5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2475854 | vericiguat 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2475855 | vericiguat 2.5 MG [Verquvo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2475856 | Verquvo 2.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2475856 | Verquvo 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475856 | Verquvo 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475857 | vericiguat 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2475858 | vericiguat 5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2475858 | vericiguat 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475858 | vericiguat 5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2475858 | vericiguat 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2475859 | vericiguat 5 MG [Verquvo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2475860 | Verquvo 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2475860 | Verquvo 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475860 | Verquvo 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475861 | collagenase clostridium histolyticum-aaes | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2475862 | collagenase clostridium histolyticum-aaes 0.92 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2475863 | collagenase clostridium histolyticum-aaes 0.92 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475863 | collagenase clostridium histolyticum-aaes 0.92 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2475864 | Qwo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2475865 | collagenase clostridium histolyticum-aaes 0.92 MG [Qwo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2475866 | collagenase Clostridium histolyticum Injection [Qwo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2475867 | Qwo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2475868 | Qwo 0.92 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2475868 | Qwo 0.92 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475868 | Qwo 0.92 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2475869 | collagenase clostridium histolyticum-aaes 1.84 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2475870 | collagenase clostridium histolyticum-aaes 1.84 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475870 | collagenase clostridium histolyticum-aaes 1.84 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2475871 | collagenase clostridium histolyticum-aaes 1.84 MG [Qwo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2475872 | Qwo 1.84 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2475872 | Qwo 1.84 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2475872 | Qwo 1.84 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247588 | thioproperazine 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247589 | fluPHENAZine 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247589 | fluPHENAZine 2 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 24759 | Pentalenene synthase | Designated preferred name (PT) | NO | |
| RxCUI: 24759 | Pentalenene synthase | Full form of descriptor (FN) | NO | |
| RxCUI: 247593 | dimethyl sulfoxide 700 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2475947 | (2-carbethoxyethyl)triethoxysilane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2475951 | 2,3-dimercaptosuccinic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2475951 | 2,3-dimercaptosuccinic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2475952 | acetamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2475954 | palmitoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2475955 | palmitoleic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2475956 | Gluconic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2475956 | Gluconic acid | Designated preferred name (PT) | YES | |
| RxCUI: 2475956 | Gluconic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 2475957 | potassium phosphate dibasic trihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2476004 | acetyl tetrapeptide-2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2476006 | N5-((2E)-((2-(((2,3-bis(omega-methoxypoly(oxyethylene))propoxy)carbonyl)amino)ethoxy)imino)ethyl)glutamine (43000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2476007 | polyglyceryl-3 methylglucose distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2476008 | Sulfachlorpyridazine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2476008 | Sulfachlorpyridazine | Designated preferred name (PT) | YES | |
| RxCUI: 2476008 | Sulfachlorpyridazine | Full form of descriptor (FN) | YES | |
| RxCUI: 2476008 | Sulfachlorpyridazine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| RxCUI: 2476009 | sulfachlorpyridazine sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2476018 | Vardenafil hydrochloride anhydrous | Designated preferred name (PT) | NO | |
| RxCUI: 2476018 | Vardenafil hydrochloride anhydrous | Full form of descriptor (FN) | NO | |
| RxCUI: 247617 | benzocaine 12 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247618 | cysteine 750 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247619 | leucine 600 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247620 | bismuth subsalicylate 262 MG / calcium carbonate 350 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247621 | idoxuridine 0.1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247621 | idoxuridine 0.1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247621 | idoxuridine 0.1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247626 | oxyCODONE 10 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247626 | oxyCODONE 10 MG Rectal Suppository | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 247627 | oxyCODONE 20 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247627 | oxyCODONE 20 MG Rectal Suppository | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 247630 | ketoprofen 50 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247630 | ketoprofen 50 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247636 | manganese gluconate 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247637 | hydroxocobalamin 0.05 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247638 | Fluorometholone 0.1 % / Neomycin 0.5 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247638 | Fluorometholone 0.1 % / Neomycin 0.5 % Ophthalmic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247646 | allyl sulfide 1250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247647 | Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 247647 | Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247647 | Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247647 | Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247647 | Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 247648 | chlorphenesin 10 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247649 | simethicone 160 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247650 | acetaminophen 160 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247650 | acetaminophen 160 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247650 | acetaminophen 160 MG Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247653 | APAP 325 MG / Meprobamate 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247653 | APAP 325 MG / Meprobamate 400 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247659 | flunarizine 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247661 | acetaminophen 80 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247661 | acetaminophen 80 MG in 1 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247661 | acetaminophen 80 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2476630 | 10-hydroxy-octadecanoic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2476630 | 10-hydroxy-octadecanoic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2476631 | ethyl hexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2476631 | ethyl hexanoate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2476632 | Opuntia ficus indica leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2476636 | Sesquient | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2476637 | fosphenytoin sodium 75 MG/ML [Sesquient] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2476638 | fosphenytoin Injection [Sesquient] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2476639 | Sesquient Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2476640 | Sesquient 100 MG PE in 2 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2476640 | Sesquient 100 MG PE in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2476640 | Sesquient 100 MG PE in 2 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2476640 | Sesquient 100 MG PE in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2476641 | fosphenytoin sodium 75 MG/ML Injection [Sesquient] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2476641 | fosphenytoin sodium 75 MG/ML Injection [Sesquient] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2476642 | bismuth subsalicylate Chewable Tablet [Kaopectate Reformulated Aug 2006] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2476643 | Kaopectate Reformulated Aug 2006 Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2476644 | Kaopectate 262 MG Chewable Tablet, Reformulated Aug 2006 | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2476644 | Kaopectate 262 MG Chewable Tablet, Reformulated Aug 2006 | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2476644 | Kaopectate 262 MG Chewable Tablet, Reformulated Aug 2006 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247667 | potassium gluconate 2.5 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247667 | potassium gluconate 2.5 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247667 | potassium gluconate 2.5 MEQ Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 247667 | potassium gluconate 2.5 MEQ Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 247667 | potassium gluconate 2.5 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2476701 | Xylimelts | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2476702 | xylitol 550 MG [Xylimelts] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2476703 | xylitol Oral Lozenge [Xylimelts] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2476704 | Xylimelts Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2476705 | Xylimelts Lozenge Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2476706 | Xylimelts 550 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2476706 | Xylimelts 550 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2476706 | Xylimelts 550 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 247671 | germanium 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247673 | metroNIDAZOLE 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247673 | metroNIDAZOLE 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247673 | metroNIDAZOLE 500 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 247682 | salicylic acid 3 % / sulfur 5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247682 | salicylic acid 3 % / sulfur 5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247682 | salicylic acid 3 % / sulfur 5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247683 | sulfur 2.5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247683 | sulfur 2.5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247683 | sulfur 2.5 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247684 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 247684 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 247684 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247684 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247684 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247684 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247684 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 247684 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 247685 | sulfur 20.8 MG/ML Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247686 | tixocortol pivalate 2.5 MG/ML Enema | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247687 | erythromycin 0.04 MG/MG / tretinoin 0.0005 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247689 | formic acid 8 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247689 | formic acid 8 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247689 | formic acid 8 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247691 | budesonide 100 MCG/ACTUAT Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247691 | budesonide 100 MCG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247691 | budesonide 100 MCG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247691 | budesonide 100 MCG/ACTUAT Nasal Spray | Designated preferred name (PT) | NO | |
| RxCUI: 247691 | budesonide 100 MCG/ACTUAT Nasal Spray | Full form of descriptor (FN) | NO | |
| RxCUI: 247692 | phosphatidylcholine 3 GM per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 247692 | phosphatidylcholine 3 GM per 5 ML Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 247692 | phosphatidylcholine 3 GM per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247694 | chlorophyll 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247694 | chlorophyll 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2476943 | cetylpyridinium chloride 0.05 % Mucosal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2476943 | cetylpyridinium chloride 0.05 % Mucosal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2476943 | cetylpyridinium chloride 0.05 % Mucosal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247705 | benzocaine 20 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247706 | benzocaine 100 MG/ML Oral Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477103 | tepotinib | Full form of descriptor (FN) | YES | |
| RxCUI: 2477103 | tepotinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2477103 | tepotinib | Designated preferred name (PT) | YES | |
| RxCUI: 2477103 | tepotinib | Full form of descriptor (FN) | YES | |
| RxCUI: 2477103 | tepotinib | Designated preferred name (PT) | YES | |
| RxCUI: 2477104 | tepotinib hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2477104 | tepotinib hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 2477104 | tepotinib hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 2477125 | Minocycline only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477125 | Minocycline only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477126 | Monomethyl fumarate only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477126 | Monomethyl fumarate only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477127 | Monomethyl fumarate only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477127 | Monomethyl fumarate only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477128 | Nelarabine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477128 | Nelarabine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477129 | Nitric oxide only product in gas for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2477129 | Nitric oxide only product in gas for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2477130 | Product containing only selpercatinib (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477130 | Product containing only selpercatinib (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477131 | Product containing only selpercatinib in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477131 | Product containing only selpercatinib in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2477132 | Product containing only somapacitan (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477132 | Product containing only somapacitan (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477133 | Product containing only somapacitan in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477133 | Product containing only somapacitan in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2477134 | Arsenic trioxide only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477134 | Arsenic trioxide only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477135 | Atazanavir and ritonavir only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477135 | Atazanavir and ritonavir only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477136 | Atazanavir and ritonavir only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477136 | Atazanavir and ritonavir only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477137 | Nitrous oxide and oxygen only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477137 | Nitrous oxide and oxygen only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477138 | Nitrous oxide only product in gas for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2477138 | Nitrous oxide only product in gas for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2477139 | Oblimersen only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477139 | Oblimersen only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477140 | Ofatumumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477140 | Ofatumumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477141 | Olaparib only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477141 | Olaparib only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477142 | Oliceridine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477142 | Oliceridine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477143 | Oliceridine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477143 | Oliceridine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477144 | Soya bean oil only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477144 | Soya bean oil only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477144 | Soya bean oil only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477145 | Soya bean oil refined only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477145 | Soya bean oil refined only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477145 | Soya bean oil refined only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477146 | Soya bean oil refined only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477146 | Soya bean oil refined only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477146 | Soya bean oil refined only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477147 | Pneumococcal 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477147 | Pneumococcal 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477147 | Pneumococcal 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2477147 | Pneumococcal 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2477150 | Atoltivimab and maftivimab and odesivimab only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477150 | Atoltivimab and maftivimab and odesivimab only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477151 | Atoltivimab and maftivimab and odesivimab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477151 | Atoltivimab and maftivimab and odesivimab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477152 | Azacitidine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477152 | Azacitidine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477153 | Azacitidine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477153 | Azacitidine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477154 | Bamlanivimab only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477154 | Bamlanivimab only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477155 | Bamlanivimab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477155 | Bamlanivimab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477156 | Bazedoxifene only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477156 | Bazedoxifene only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477157 | Bazedoxifene only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477157 | Bazedoxifene only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477158 | Belantamab mafodotin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477158 | Belantamab mafodotin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477159 | Belantamab mafodotin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477159 | Belantamab mafodotin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477161 | Oxybuprocaine only product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477161 | Oxybuprocaine only product in ocular dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477161 | Oxybuprocaine only product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477162 | Bilastine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477162 | Bilastine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477163 | Bilastine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477163 | Bilastine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477164 | Bortezomib only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477164 | Bortezomib only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477165 | Brentuximab vedotin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477165 | Brentuximab vedotin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477166 | Brexucabtagene autoleucel only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477166 | Brexucabtagene autoleucel only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477167 | Brexucabtagene autoleucel only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477167 | Brexucabtagene autoleucel only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477168 | Product containing only tafasitamab (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477168 | Product containing only tafasitamab (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477169 | Product containing only tafasitamab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477169 | Product containing only tafasitamab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 247717 | folate 1 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247717 | folate 1 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477170 | Product containing only trastuzumab emtansine (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477170 | Product containing only trastuzumab emtansine (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477171 | Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477171 | Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2477172 | Calcium carbonate only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477172 | Calcium carbonate only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477173 | Calcium oxybate and magnesium oxybate and potassium oxybate and sodium oxybate only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477173 | Calcium oxybate and magnesium oxybate and potassium oxybate and sodium oxybate only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477174 | Calcium oxybate and magnesium oxybate and potassium oxybate and sodium oxybate only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477174 | Calcium oxybate and magnesium oxybate and potassium oxybate and sodium oxybate only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477175 | Canakinumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477175 | Canakinumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477176 | Capmatinib only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477176 | Capmatinib only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477177 | Capmatinib only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477177 | Capmatinib only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477178 | Product containing only triheptanoin (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477178 | Product containing only triheptanoin (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477179 | Product containing only triheptanoin in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477179 | Product containing only triheptanoin in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 247718 | polysaccharide iron complex 1.11 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477180 | Carbon (13-C) urea only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477180 | Carbon (13-C) urea only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477181 | Carbon (13-C) urea only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477181 | Carbon (13-C) urea only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477182 | Carbon dioxide and oxygen only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477182 | Carbon dioxide and oxygen only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477183 | Carbon dioxide only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477183 | Carbon dioxide only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477184 | Cedazuridine and decitabine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477184 | Cedazuridine and decitabine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477185 | Cedazuridine and decitabine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477185 | Cedazuridine and decitabine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477186 | Chondroitin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477186 | Chondroitin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477187 | Product containing only valrubicin in intravesical dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477187 | Product containing only valrubicin in intravesical dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2477188 | Product containing only vandetanib in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477188 | Product containing only vandetanib in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2477189 | Product containing only viltolarsen (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477189 | Product containing only viltolarsen (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 247719 | FESO4 45 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247719 | FESO4 45 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477190 | Product containing only viltolarsen in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477190 | Product containing only viltolarsen in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2477191 | Product containing only vinflunine (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477191 | Product containing only vinflunine (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477192 | Product containing only vinflunine in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477192 | Product containing only vinflunine in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2477193 | Product containing only wool alcohol in ocular dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477193 | Product containing only wool alcohol in ocular dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2477194 | Clascoterone only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477194 | Clascoterone only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477195 | Clascoterone only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477195 | Clascoterone only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477196 | Coagulation factor V only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477196 | Coagulation factor V only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477197 | Coagulation factor VII only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477197 | Coagulation factor VII only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477198 | Copper (64-Cu) dotatate only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477198 | Copper (64-Cu) dotatate only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477199 | Copper (64-Cu) dotatate only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477199 | Copper (64-Cu) dotatate only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 247720 | edoxudine 30 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477200 | Cyclizine and morphine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477200 | Cyclizine and morphine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477201 | Dimeticone and loperamide only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477201 | Dimeticone and loperamide only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477201 | Dimeticone and loperamide only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477202 | Dulaglutide only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477202 | Dulaglutide only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477203 | Hydroxyapatite only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477203 | Hydroxyapatite only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477203 | Hydroxyapatite only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477204 | Efavirenz and lamivudine and tenofovir only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477204 | Efavirenz and lamivudine and tenofovir only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477205 | Efavirenz and lamivudine and tenofovir only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477205 | Efavirenz and lamivudine and tenofovir only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477206 | Elagolix and estradiol and norethisterone only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477206 | Elagolix and estradiol and norethisterone only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477206 | Elagolix and estradiol and norethisterone only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477207 | Elagolix and estradiol and norethisterone only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477207 | Elagolix and estradiol and norethisterone only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477207 | Elagolix and estradiol and norethisterone only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477208 | Pertuzumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477208 | Pertuzumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477209 | Fenfluramine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477209 | Fenfluramine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477210 | Flortaucipir (18-F) only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477210 | Flortaucipir (18-F) only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477211 | Flortaucipir (18-F) only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477211 | Flortaucipir (18-F) only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477212 | Polyestradiol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477212 | Polyestradiol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477213 | Polystyrene sulfonate only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477213 | Polystyrene sulfonate only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477214 | Polystyrene sulfonate only product in rectal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477214 | Polystyrene sulfonate only product in rectal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477215 | Porcine insulin soluble and porcine isophane insulin only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477215 | Porcine insulin soluble and porcine isophane insulin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477215 | Porcine insulin soluble and porcine isophane insulin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477216 | Porcine insulin soluble and porcine isophane insulin only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477216 | Porcine insulin soluble and porcine isophane insulin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477216 | Porcine insulin soluble and porcine isophane insulin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477217 | Porcine isophane insulin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477217 | Porcine isophane insulin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477218 | Fluoroestradiol (18-F) only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477218 | Fluoroestradiol (18-F) only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477219 | Fluoroestradiol (18-F) only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477219 | Fluoroestradiol (18-F) only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477220 | Fostemsavir only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477220 | Fostemsavir only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477221 | Fostemsavir only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477221 | Fostemsavir only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477222 | Haemophilus influenzae type b and meningitis C and Y vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477222 | Haemophilus influenzae type b and meningitis C and Y vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2477222 | Haemophilus influenzae type b and meningitis C and Y vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2477223 | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2477223 | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477223 | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2477224 | Pralatrexate only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477224 | Pralatrexate only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477225 | Pralsetinib only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477225 | Pralsetinib only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477226 | Pralsetinib only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477226 | Pralsetinib only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477227 | Helium and nitrogen and oxygen only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477227 | Helium and nitrogen and oxygen only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477228 | Helium and nitrogen and oxygen only product in gas for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2477228 | Helium and nitrogen and oxygen only product in gas for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2477229 | Helium and oxygen only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477229 | Helium and oxygen only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477230 | Human isophane insulin and recombinant human soluble insulin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477230 | Human isophane insulin and recombinant human soluble insulin only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477230 | Human isophane insulin and recombinant human soluble insulin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477231 | Human isophane insulin and recombinant human soluble insulin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477231 | Human isophane insulin and recombinant human soluble insulin only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477231 | Human isophane insulin and recombinant human soluble insulin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477232 | Human isophane insulin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477232 | Human isophane insulin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477233 | Idelalisib only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477233 | Idelalisib only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477234 | Inactivated whole Hepatitis A GBM strain vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477234 | Inactivated whole Hepatitis A GBM strain vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2477234 | Inactivated whole Hepatitis A GBM strain vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2477235 | Inactivated whole Hepatitis A HM-175 strain vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477235 | Inactivated whole Hepatitis A HM-175 strain vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2477235 | Inactivated whole Hepatitis A HM-175 strain vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2477236 | Inactivated whole Influenza H5N1 vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2477236 | Inactivated whole Influenza H5N1 vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477236 | Inactivated whole Influenza H5N1 vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2477237 | Abametapir only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477237 | Abametapir only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477238 | Abametapir only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477238 | Abametapir only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477239 | Inebilizumab only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477239 | Inebilizumab only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477240 | Inebilizumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477240 | Inebilizumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477241 | Influenza H5N1 vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2477241 | Influenza H5N1 vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477241 | Influenza H5N1 vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2477242 | Insulin lispro and insulin lispro protamine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477242 | Insulin lispro and insulin lispro protamine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477243 | Live attenuated Oka strain varicella vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2477243 | Live attenuated Oka strain varicella vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477243 | Live attenuated Oka strain varicella vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2477244 | Live attenuated Oka-Merck strain varicella vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2477244 | Live attenuated Oka-Merck strain varicella vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477244 | Live attenuated Oka-Merck strain varicella vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2477245 | Live attenuated influenza vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477245 | Live attenuated influenza vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2477245 | Live attenuated influenza vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2477246 | Agomelatine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477246 | Agomelatine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477247 | Air and carbon dioxide only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477247 | Air and carbon dioxide only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477248 | Air and carbon dioxide only product in gas for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2477248 | Air and carbon dioxide only product in gas for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2477249 | Tdap - Low dose diphtheria and low dose acellular pertussis and tetanus vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2477249 | Tdap - Low dose diphtheria and low dose acellular pertussis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477249 | Tdap - Low dose diphtheria and low dose acellular pertussis and tetanus vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2477250 | Lurbinectedin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2477250 | Lurbinectedin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477251 | Lurbinectedin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477251 | Lurbinectedin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477252 | Phenazone only product in otic dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477252 | Phenazone only product in otic dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477252 | Phenazone only product in otic dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477253 | Product containing only remimazolam (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477253 | Product containing only remimazolam (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477254 | Product containing only remimazolam in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477254 | Product containing only remimazolam in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2477255 | Product containing only rimegepant in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477255 | Product containing only rimegepant in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2477256 | Product containing only ripretinib (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477256 | Product containing only ripretinib (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477257 | Product containing only ripretinib in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477257 | Product containing only ripretinib in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2477258 | Product containing only risdiplam (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477258 | Product containing only risdiplam (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477259 | Product containing only risdiplam in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477259 | Product containing only risdiplam in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 247726 | hydrocortisone 0.01 MG/MG / neomycin 0.005 MG/MG Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477260 | Product containing only satralizumab (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477260 | Product containing only satralizumab (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477261 | Product containing only satralizumab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477261 | Product containing only satralizumab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2477262 | tepotinib 225 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2477263 | tepotinib Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2477263 | tepotinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2477263 | tepotinib Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2477264 | tepotinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2477265 | tepotinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2477266 | tepotinib 225 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2477266 | tepotinib 225 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2477266 | tepotinib 225 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2477266 | tepotinib 225 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2477266 | tepotinib 225 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2477267 | Tepmetko | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2477268 | tepotinib 225 MG [Tepmetko] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2477269 | tepotinib Oral Tablet [Tepmetko] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2477270 | Tepmetko Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2477271 | Tepmetko Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2477272 | TEPMETKO 225 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2477272 | TEPMETKO 225 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2477272 | TEPMETKO 225 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2477272 | TEPMETKO 225 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2477274 | Acetylcholine-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477274 | Acetylcholine-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477275 | Adrenergic receptor antagonist-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477275 | Adrenergic receptor antagonist-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477276 | Air- and carbon dioxide-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477276 | Air- and carbon dioxide-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477277 | Artemisinin-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477277 | Artemisinin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477278 | Air- and carbon dioxide-containing product in gas for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2477278 | Air- and carbon dioxide-containing product in gas for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2477279 | Artenimol-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477279 | Artenimol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 247728 | calcium carbonate 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477280 | Alpha-adrenergic and beta-adrenergic agonist-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477280 | Alpha-adrenergic and beta-adrenergic agonist-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477281 | Artenimol-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477281 | Artenimol-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477282 | Atazanavir- and ritonavir-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477282 | Atazanavir- and ritonavir-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477283 | Oxybuprocaine-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477283 | Oxybuprocaine-containing product in ocular dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477283 | Oxybuprocaine-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477284 | Bilastine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477284 | Bilastine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477285 | Calcium carbonate-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477285 | Calcium carbonate-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477286 | Chondroitin-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477286 | Chondroitin-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477287 | Coagulation factor V-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477287 | Coagulation factor V-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477288 | petrolatum 459 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2477289 | benzocaine 10 % / petrolatum 45.9 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2477289 | benzocaine 10 % / petrolatum 45.9 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477289 | benzocaine 10 % / petrolatum 45.9 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477290 | Calcium oxybate- and magnesium oxybate- and potassium oxybate- and sodium oxybate-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477290 | Calcium oxybate- and magnesium oxybate- and potassium oxybate- and sodium oxybate-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477291 | Coagulation factor-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477291 | Coagulation factor-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477291 | Coagulation factor-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477291 | Coagulation factor-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477292 | Copper (64-Cu) dotatate-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477292 | Copper (64-Cu) dotatate-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477293 | Copper-62-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477293 | Copper-62-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477295 | Flortaucipir (18-F)-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477295 | Flortaucipir (18-F)-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477296 | Fluoroestradiol (18-F)-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477296 | Fluoroestradiol (18-F)-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477297 | Genetically modified virus-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477297 | Genetically modified virus-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477299 | chlorhexidine gluconate 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 247730 | calcium gluconate 5.8 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477300 | chlorhexidine gluconate 2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477300 | chlorhexidine gluconate 2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2477300 | chlorhexidine gluconate 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477301 | Mineral-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477301 | Mineral-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477302 | Nitrous oxide- and oxygen-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477302 | Nitrous oxide- and oxygen-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477303 | Nitrous oxide- and oxygen-containing product in gas for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2477303 | Nitrous oxide- and oxygen-containing product in gas for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2477304 | Oblimersen-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477304 | Oblimersen-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477305 | Oxyquinoline structure-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477305 | Oxyquinoline structure-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477307 | Penicillin-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477307 | Penicillin-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477309 | Piperaquine-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477309 | Piperaquine-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 247731 | manganese gluconate 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477310 | Bilastine 10 mg orodispersible tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2477310 | Bilastine 10 mg orodispersible tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2477311 | Plasma protein-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477311 | Plasma protein-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477312 | Podophyllotoxin and/or podophyllotoxin derivative-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477312 | Podophyllotoxin and/or podophyllotoxin derivative-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477313 | Product containing precisely secukinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477313 | Product containing precisely secukinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2477314 | Nitrous oxide 50% and oxygen 50% gas for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2477314 | Nitrous oxide 50% and oxygen 50% gas for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477314 | Nitrous oxide 50% and oxygen 50% gas for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477314 | Nitrous oxide 50% and oxygen 50% gas for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2477315 | Polystyrene sulfonate-containing product in rectal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477315 | Polystyrene sulfonate-containing product in rectal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477316 | Recombinant DNA-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477316 | Recombinant DNA-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477316 | Recombinant DNA-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477317 | Product containing recombinant interleukin 2 (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477317 | Product containing recombinant interleukin 2 (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477318 | Product containing selective progesterone receptor modulator (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477318 | Product containing selective progesterone receptor modulator (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477319 | Product containing somapacitan (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477319 | Product containing somapacitan (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 247732 | manganese gluconate 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477321 | Soya bean oil refined-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2477321 | Soya bean oil refined-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477321 | Soya bean oil refined-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2477322 | Soya bean oil refined-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477322 | Soya bean oil refined-containing product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477322 | Soya bean oil refined-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477323 | Product containing trastuzumab emtansine in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477323 | Product containing trastuzumab emtansine in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2477324 | Medicinal product containing Vinca alkaloid and acting as antineoplastic agent (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477324 | Medicinal product containing Vinca alkaloid and acting as antineoplastic agent (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477325 | Product containing vinflunine (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477325 | Product containing vinflunine (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477326 | Product containing vinflunine in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477326 | Product containing vinflunine in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2477327 | Product containing wool alcohol in ocular dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477327 | Product containing wool alcohol in ocular dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 247733 | Monobasic Pot phosphate 176 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247733 | Monobasic Pot phosphate 176 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247733 | Monobasic Pot phosphate 176 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247734 | K+ Chloride 12 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247734 | K+ Chloride 12 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247734 | K+ Chloride 12 MEQ Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247738 | ZnSO4 1.35 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247738 | ZnSO4 1.35 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247741 | choline 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247742 | inositol 400 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247743 | piperacetazine 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477431 | antimony trioxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 247744 | dichloralphenazone 650 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247745 | sodium salicylate 570 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247747 | niacin 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 247747 | niacin 500 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 247747 | niacin 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 247747 | niacin 500 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247747 | niacin 500 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 247747 | niacin 500 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247747 | niacin 500 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 247748 | pantothenic acid 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247749 | vitamin C 850 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247749 | vitamin C 850 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247749 | vitamin C 850 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247750 | ascorbic acid 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247750 | ascorbic acid 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247750 | ascorbic acid 400 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247750 | ascorbic acid 400 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247751 | vit-C 550 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247751 | vit-C 550 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247751 | vit-C 550 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247752 | beta carotene 2000 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477530 | hydrogen peroxide 0.0214 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2477531 | hydrogen peroxide Oral Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2477532 | hydrogen peroxide Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2477533 | hydrogen peroxide Toothpaste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2477534 | hydrogen peroxide Toothpaste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2477535 | hydrogen peroxide 2.14 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477535 | hydrogen peroxide 2.14 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2477535 | hydrogen peroxide 2.14 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477536 | camphor 5 % / methyl salicylate 50 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2477536 | camphor 5 % / methyl salicylate 50 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477536 | camphor 5 % / methyl salicylate 50 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477549 | Metoprolol tartrate 1 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2477549 | Metoprolol tartrate 1 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 247755 | ethanol 2 ML/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477559 | Medicinal product containing sulfonamide and acting as diuretic agent (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477559 | Medicinal product containing sulfonamide and acting as diuretic agent (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477563 | Substance with tetracyclic structure | Designated preferred name (PT) | NO | |
| RxCUI: 2477563 | Substance with tetracyclic structure | Full form of descriptor (FN) | NO | |
| RxCUI: 2477568 | Varenicline dihydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 2477568 | Varenicline dihydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 247757 | calcium ascorbate 250 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477573 | Lapatinib ditosylate monohydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2477573 | Lapatinib ditosylate monohydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2477574 | Halofuginone hydrobromide | Designated preferred name (PT) | NO | |
| RxCUI: 2477574 | Halofuginone hydrobromide | Full form of descriptor (FN) | NO | |
| RxCUI: 2477576 | Selective progesterone receptor modulator | Designated preferred name (PT) | NO | |
| RxCUI: 2477576 | Selective progesterone receptor modulator | Full form of descriptor (FN) | NO | |
| RxCUI: 2477577 | Recombinant interleukin 2 | Designated preferred name (PT) | NO | |
| RxCUI: 2477577 | Recombinant interleukin 2 | Full form of descriptor (FN) | NO | |
| RxCUI: 247758 | calcium ascorbate 550 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477580 | Recombinant coagulation factor VIII | Designated preferred name (PT) | NO | |
| RxCUI: 2477580 | Recombinant coagulation factor VIII | Full form of descriptor (FN) | NO | |
| RxCUI: 2477581 | Recombinant coagulation factor VII | Designated preferred name (PT) | NO | |
| RxCUI: 2477581 | Recombinant coagulation factor VII | Full form of descriptor (FN) | NO | |
| RxCUI: 2477583 | Medicinal product containing purine and/or purine derivative and acting as diuretic agent (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477583 | Medicinal product containing purine and/or purine derivative and acting as diuretic agent (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477589 | Hydroxocobalamin chloride | Designated preferred name (PT) | NO | |
| RxCUI: 2477589 | Hydroxocobalamin chloride | Full form of descriptor (FN) | NO | |
| RxCUI: 247759 | flumethasone 0.0002 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477590 | Semduramicin sodium | Designated preferred name (PT) | NO | |
| RxCUI: 2477590 | Semduramicin sodium | Full form of descriptor (FN) | NO | |
| RxCUI: 2477591 | Messenger ribonucleic acid of 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477591 | Messenger ribonucleic acid of 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477591 | Messenger ribonucleic acid of 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477591 | Messenger ribonucleic acid of 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477591 | Messenger ribonucleic acid of 2019-nCoV | Full form of descriptor (FN) | NO | |
| RxCUI: 2477591 | Messenger ribonucleic acid of 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477591 | Messenger ribonucleic acid of 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477591 | Messenger ribonucleic acid of 2019-nCoV | Designated preferred name (PT) | NO | |
| RxCUI: 2477592 | Oxazolidinone | Designated preferred name (PT) | NO | |
| RxCUI: 2477592 | Oxazolidinone | Full form of descriptor (FN) | NO | |
| RxCUI: 2477593 | Substance with adrenergic receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2477593 | Substance with adrenergic receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2477594 | Beta-lactamase inhibitor antibacterial agent | Designated preferred name (PT) | NO | |
| RxCUI: 2477594 | Beta-lactamase inhibitor antibacterial agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2477595 | Bialamicol | Designated preferred name (PT) | NO | |
| RxCUI: 2477595 | Bialamicol | Full form of descriptor (FN) | NO | |
| RxCUI: 2477597 | Thiazide | Designated preferred name (PT) | NO | |
| RxCUI: 2477597 | Thiazide | Full form of descriptor (FN) | NO | |
| RxCUI: 2477599 | Triazene | Designated preferred name (PT) | NO | |
| RxCUI: 2477599 | Triazene | Full form of descriptor (FN) | NO | |
| RxCUI: 247760 | urea 50 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 247760 | urea 50 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 247760 | urea 50 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 247760 | urea 50 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2477600 | Medicinal product containing triazene and acting as antineoplastic agent (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2477600 | Medicinal product containing triazene and acting as antineoplastic agent (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2477602 | Trifluridine hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 2477602 | Trifluridine hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 2477604 | Perindopril erbumine monohydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2477604 | Perindopril erbumine monohydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 247762 | lactic acid 0.04 MG/MG / salicylic acid 0.11 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2477635 | Bilastine 2.5 mg/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2477635 | Bilastine 2.5 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2477636 | Bilastine 20 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2477636 | Bilastine 20 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2477637 | melatonin 1 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2477637 | melatonin 1 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2477638 | Bilastine-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477638 | Bilastine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477639 | Miltefosine 10 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2477639 | Miltefosine 10 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2477640 | Mifepristone 600 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2477640 | Mifepristone 600 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2477641 | Misoprostol 400 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2477641 | Misoprostol 400 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2477642 | Nevirapine 50 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2477642 | Nevirapine 50 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2477643 | Atazanavir (as atazanavir sulfate) 300 mg and ritonavir 100 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2477643 | Atazanavir (as atazanavir sulfate) 300 mg and ritonavir 100 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2477644 | Atazanavir- and ritonavir-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2477644 | Atazanavir- and ritonavir-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2477645 | Azilsartan medoxomil (as azilsartan medoxomil potassium) 20 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2477645 | Azilsartan medoxomil (as azilsartan medoxomil potassium) 20 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2477647 | Bazedoxifene (as bazedoxifene acetate) 20 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2477647 | Bazedoxifene (as bazedoxifene acetate) 20 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 24 |